What is the most likely causative organism in a patient with community-acquired pneumonia (CAP) presenting with shortness of breath, unilateral dullness, and left lower lobe consolidation on x-ray?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Causative Organism in Community-Acquired Pneumonia with Lobar Consolidation

The most likely causative organism is B. Streptococcus pneumoniae, which remains the predominant bacterial pathogen in community-acquired pneumonia presenting with lobar consolidation, regardless of age or comorbidities 1.

Evidence Supporting Streptococcus pneumoniae as the Primary Pathogen

Streptococcus pneumoniae is consistently identified as the most common bacterial cause of CAP across multiple international guidelines:

  • In Taiwan, S. pneumoniae accounts for 23-26% of identified CAP cases and is the predominant pathogen in patients older than 60 years (28.7% prevalence) 1
  • European guidelines confirm S. pneumoniae as the leading extracellular bacterial pathogen in both community and hospital ward settings 1
  • In severe CAP requiring ICU admission, S. pneumoniae remains the most common bacterial pathogen with an overall incidence of 41.7% and represents over 80% of all bacteremia cases 1
  • Recent U.S. data show that among patients with an identified pathogen, S. pneumoniae is found in approximately 15% of hospitalized CAP cases 2

Clinical Presentation Characteristics

The clinical presentation described—unilateral dullness with left lower lobe consolidation—is classic for pneumococcal pneumonia:

  • Lobar consolidation on chest radiograph is the typical radiographic pattern associated with S. pneumoniae infection 1
  • Pneumococcal pneumonia characteristically presents with acute onset of symptoms, including shortness of breath, productive cough, and focal consolidation 3

Why Other Options Are Less Likely

Haemophilus influenzae (Option D) accounts for only 5-9% of CAP cases in Taiwan and 3-10% globally, making it significantly less common than S. pneumoniae 1, 4. It is more frequently associated with patients who smoke or have chronic obstructive pulmonary disease 5, 6.

Staphylococcus aureus (Option A) is an uncommon cause of community-acquired pneumonia unless there are specific risk factors such as post-influenza infection, intravenous drug use, or recent viral illness 1. It typically presents with cavitary lesions or necrotizing pneumonia rather than simple lobar consolidation 1.

Pseudomonas aeruginosa (Option C) is found in only 2% of identified CAP pathogens and is primarily seen in patients with structural lung disease (bronchiectasis), prior antibiotic therapy, corticosteroid use, or septic shock on admission 1. It is not a typical cause of uncomplicated lobar pneumonia in otherwise healthy patients 1.

Important Clinical Caveats

  • Despite S. pneumoniae being the most likely pathogen, no causative organism is identified in 40-70% of CAP cases even with extensive diagnostic testing 5, 7
  • Mixed infections (bacterial plus viral or bacterial plus atypical pathogen) occur in 3-30% of cases, with S. pneumoniae being the most frequent co-pathogen 1, 5
  • The diagnosis should prompt consideration of pneumococcal vaccination status, as lack of vaccination is an independent risk factor for recurrent pneumococcal pneumonia 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Community-acquired pneumonia.

Clinical medicine (London, England), 2012

Guideline

Community-Acquired Pneumonia Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Community-Acquired Pneumonia Etiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aetiology of, and risk factors for, recurrent community-acquired pneumonia.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009

Guideline

Community-Acquired Pneumonia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the types and treatment options for community-acquired pneumonia (CAP)?
What is the most likely causative organism in a patient presenting with a productive cough containing yellowish sputum and streaks of blood, and chest X-ray (CXR) showing patchy infiltrates with air bronchograms?
Is fever a symptom of Community-Acquired Pneumonia (CAP)?
What is the most likely causative organism in a patient presenting with a productive cough producing yellow sputum with blood streaks, right lower lobe infiltrate with air bronchograms on chest X-ray, and impaired renal function (elevated Blood Urea Nitrogen (BUN) and creatinine)?
What is the definition, signs and symptoms, diagnosis, evaluation, treatment guidelines, and mortality and morbidity factors of Community-Acquired Pneumonia (CAP)?
Should colistin be stopped or completed for 21 days in a patient with a Candida infection who is also on amphotericin?
What is the role of diuretics, such as furosemide (loop diuretic) or hydrochlorothiazide (thiazide diuretic), in managing fluid overload and hypertension in patients with anti-glomerular basement membrane (anti-GBM) disease after the initial flare?
Should IFR (Instantaneous Wave-Free Ratio) or FFR (Fractional Flow Reserve) be used to assess coronary artery disease prior to TVR (Transcatheter Aortic Valve Replacement) in patients with severe aortic stenosis?
Is physiology testing, such as Fractional Flow Reserve (FFR) or instant wave-free ratio (iFR), reliable in patients with severe aortic stenosis?
What is the preferred initial treatment between Angiotensin Receptor Neprilysin Inhibitor (ARNI) and Angiotensin Receptor Blocker (ARB) for patients with heart failure with reduced ejection fraction?
What is the recommended daily formula intake for a 10-month-old baby who is eating table food?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.